Corvia Medical is revolutionizing the treatment of heart failure (HF) with a novel transcatheter str
Location: United States, Massachusetts, Tewksbury
Employees: 11-50
Phone: +1 978-654-6123
Total raised: $54M
Founded date: 2009
Investors 3
| Date | Name | Website |
| - | Lumira Ven... | lumiravent... |
| 18.07.2021 | General Ca... | generalcat... |
| - | Arkin Hold... | arkinholdi... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 14.06.2022 | - | $54M | - |
Mentions in press and media 17
| Date | Title | Description | Source |
| 12.04.2024 | Corvia's RESPONDER-HF Confirmatory Trial Supported by RELIEV... | Second major trial for atrial shunt therapy demonstrates importance of patient selection TEWKSBURY, ... | en.prnasia... |
| 22.05.2023 | CORVIA MEDICAL RELEASES TWO-YEAR CLINICAL TRIAL RESULTS CONF... | FIRST-EVER PHASE III RANDOMIZED CONTROLLED TRIAL OF ATRIAL SHUNT THERAPY SHOWS CONTINUED PROMISE TEW... | en.prnasia... |
| 06.12.2022 | CORVIA MEDICAL ANNOUNCES RANDOMIZATION OF FIRST PATIENT IN T... | Corvia® Atrial Shunt has the potential to change the way heart failure is treated TEWKSBURY, Mass., ... | en.prnasia... |
| 14.06.2022 | Corvia Medical Closed $54 Million Financing to Support Plann... | Existing investor syndicate supports atrial shunting as effective therapy for heart failure patients | lumiravent... |
| 13.06.2022 | Corvia Medical Closes USD54M Funding | Corvia Medical, a Tewksbury, MA-based company dedicated to transforming the treatment of heart failu... | finsmes.co... |
| 09.06.2022 | Corvia Medical closes $54M financing to support atrial shunt | The Corvia atrial shunt [Image from Corvia Medical]Corvia Medical announced today that it closed a $... | massdevice... |
| 09.06.2022 | Corvia Medical Raises $54M | TEWKSBURY, MA, Corvia Medical today announced the closing of a $54 million equity financing from i... | vcnewsdail... |
| 01.04.2022 | REDUCE LAP-HF II ANALYSES SHOW 50% OF STUDY PATIENTS DEMONST... | Landmark trial advances understanding of which HFpEF patients may benefit from atrial shunt therapy ... | en.prnasia... |
| 02.02.2022 | LANDMARK REDUCE LAP-HF II TRIAL DEMONSTRATES CLINICAL BENEFI... | REDUCE LAP-HF II study defines treatable HFpEF patient population for atrial shunt therapy TEWKSBURY... | en.prnasia... |
| 01.02.2022 | LANDMARK REDUCE LAP-HF II TRIAL DEMONSTRATES CLINICAL BENEFI... | REDUCE LAP-HF II study defines treatable HFpEF patient population for atrial shunt therapy TEWKSBURY... | en.prnasia... |
Show more